Google
NVCR — NOVOCURE LTD (Healthcare >> Medical Devices)
NVCR FAQ
What is NVCR's ROE?
NOVOCURE LTD reports a Return on Equity (ROE) of -52.32%.
What is NVCR's dividend yield?
NOVOCURE LTD offers a dividend yield of 0.00%.
What is NVCR's Deepscope Quality Score?
Deepscope rates NVCR's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NVCR?
Deepscope's AI Timing Score for NVCR is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NVCR belong to?
NOVOCURE LTD is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 17.78
Price
0.07
(0.40%)
Day Change
|
|
|---|
NVCR Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 90 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 17.78 |
| PBV / Sector |
6.16 / 7.44
|
| Earning Per Share | -1.51 |
| PE / Sector |
N/A / 29.54
|
| PEG or PE/Growth / Sector |
N/A / 0.40
|
| Average 1M Daily Value |
23.91 M
GREAT
|
| Average 1W Daily Value |
20.11 M
GREAT
|
| Yếu tố Kỹ thuật |
|
71% |
| Sức khỏe tài chính |
|
43% |
| Khả năng kiếm lợi nhuận |
|
60% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-13 11:13:36 |
| Symbol | NVCR |
| Name | NOVOCURE LTD |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 115.82 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2,036.71 / 18,290.40 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Neuhofstrasse 21, Baar, Switzerland, 6340
Phone: 44 15 3475 6700
Website: https://www.novocure.com
Employees: 1,605
Sector: Healthcare >> Medical Devices
Description: NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
